HitIQ Limited
AASX:HIQ0.00
AUD
+0.00
(+33.33%)
HitIQ Limited
ASX:HIQ
(Australian Securities Exchange)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- HITIQ Limited (ASX:HIQ) develops and commercializes concussion management technologies and software, focusing on instrumented mouthguards and platforms for head impact monitoring, assessment, and rehabilitation in sports; its core products include the HITIQ Smart Mouthguard and Nexus A9 system with embedded sensors to capture head impact frequency, location, and intensity, the CSX sideline concussion assessment platform generating shareable digital records, the CoVR virtual reality-based cognitive and oculomotor assessment tool, the ConneQt ecosystem linking administrators, caregivers, players, and medical professionals, and the PROTEQT system for consumer markets with real-time monitoring, subscription services, and telehealth support. Founded in 2015 and headquartered in South Melbourne, Australia, the company operates primarily in Oceania with global reach through deployments in North America, the UK, Japan, and Europe, serving professional leagues such as the Australian Football League, National Rugby League, English Premier League, Rugby Australia, Canterbury Crusaders, and World Rugby; NCAA Division 1 programs; amateur organizations including the Victorian Amateur Football Association; universities; and research entities. Recent developments encompass a landmark extension of its Premier League partnership and securing $3 million in additional convertible note funding during the December 2024 quarter to accelerate production, sales, and global commercialization; a $1.9 million capital raising via placement and rights issue in the June 2025 quarter for consumer expansion and manufacturing; the February 2025 appointment of Jennifer Tucker as Non-Executive Director to bolster governance; Harmil Angel Investments' planned conversion of $1.6 million in convertible notes to shares; over 4,000 instrumented mouthguards deployed worldwide contributing to the largest global head impact database; new Australian patent grants; and NRL adoption of its mouthguard technology for the 2024 season.